Mr.
Scott P. Serota, President and CEO of Blue Cross and Blue Shield Association,
will deliver the Opening Address of the WIN
2014 Symposium on personalized cancer
medicine, to be held in Paris on June 23 and 24. WIN Symposia are an initiative of the WIN Consortium, a non-profit global collaboration of academic, industry, health plan, and advocacy organizations dedicated to bringing the most promising advances in personalized cancer medicine to patients worldwide. Blue Cross and Blue Shield Association joined the WIN Consortium as a member in 2013. Mr. Serota will join prestigious leaders at the symposium, who will present keynote lectures during the Symposium, including: · Robert Weinberg, Cambridge, MA (USA) · René Bernards, Amsterdam (Netherlands) · Hans Clevers, Utrecht (Netherlands) · Leroy Hood, Seattle (USA) · Guido Kroemer, Villejuif (France) · Bob Löwenberg, Rotterdam (Netherlands) · Stefan Pfister, Heidelberg (Germany) Don’t miss this unique opportunity to interact directly with the world’s leaders in innovations in cancer patient management. Registration and abstract submission are open. Blue Cross and Blue Shield Association is a federation of 37 independent, community-based and locally operated Blue Cross and Blue Shield companies that collectively provide healthcare coverage for nearly 100 million members. Scott P. Serota has served Blue Cross and Blue Shield Association as President and CEO since 2000. His health plan perspectives will provide a vital link between the scientific innovations presented by prestigious leaders at the WIN 2014 Symposium and the care received by cancer patients in daily practice “Innovation in therapeutics and active cooperation
between stakeholders involved in delivering care to patients is needed to
effectively drive efficacy and quality improvement in the area of cancer care,
in a realistic societal and economic model.” “The scientific program
will address major developments in precision cancer medicine in sessions
featuring the world’s leaders in basic and clinical cancer research, each
session focusing on the rationale for combinations.” Click here to view the detailed WIN 2014 program with all lecture title s and speakers names.
|
-
Alexander Eggermont, France
|